X-linked severe combined immunodeficiency
Active Research Protocols
- 00-HG-0209 – Molecular and Clinical Studies of Primary Immunodeficiency Diseases
- 05-I-0213 – Screening and Baseline Assessment of Patients with Abnormalities of Immune Function
- 07-I-0171 – Treatment for Growth Failure in Patients with X-Linked Severe Combined Immunodeficiency (XSCID): A Phase 2 Study Assessing Safety and Clinical Response to Treatment with Insulin-like Growth Factor-1 (IGF-1)
- 11-I-0007 – Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age with X-Linked Severe Combined Immunodeficiency
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014